NINE MASTS CAPITAL Ltd

Position in CCCC — C4 Therapeutics, Inc.

CIK 1569356 CENTRAL, K3

Position in CCCC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$37,232

+$15,321 QoQ

Shares Held

14,157

+23.4% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NINE MASTS CAPITAL Ltd holds $2,069,717 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	9,400	$1,247,662
2	VERA	Vera Therapeutics, Inc.	9,434	$404,812
3	INBX	Inhibrx Biosciences, Inc.	3,000	$284,250
4	ABVX	Abivax S.A.	998	$132,993

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,232	14,157	+23.4%	Shares	Sole	2026-05-13
2025-12-31	$21,911	11,472	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.